Showing results (2231-2240 of 3,641) with videos related to

Sort By:
Pageof 365
Breast (Edinburgh, Scotland)|March 12, 2013
Validation of a breast cancer nomogram for predicting nonsentinel node metastases after minimal sentinel node involvement: validation of the Helsinki breast nomogramLobna Ouldamer, Flavie Arbion, Alexis Balagny, et al.
Breast (Edinburgh, Scotland)|December 12, 2012
Ultrasound-guided radiofrequency ablation of early breast cancer in a resection specimen: lessons for further researchD L Kreb, B G Looij, M F Ernst, et al.
Breast (Edinburgh, Scotland)|January 22, 2013
Low re-excision rate for positive margins in patients treated with ultrasound-guided breast-conserving surgeryChi-Chang Yu, Kun-Chun Chiang, Wen-Lin Kuo, et al.
Breast (Edinburgh, Scotland)|January 8, 2013
The clinical impact of the American College of Surgeons Oncology Group Z-0011 trial--results from the BreastSurgANZ National Breast Cancer AuditRachel K Ainsworth, James Kollias, Abbey Le Blanc, et al.
Breast (Edinburgh, Scotland)|January 29, 2013
Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab eraErin M Olson, Julie S Najita, Jessica Sohl, et al.
Breast (Edinburgh, Scotland)|February 19, 2013
FDG PET/CT during neoadjuvant chemotherapy may predict response in ER-positive/HER2-negative and triple negative, but not in HER2-positive breast cancerBas B Koolen, Kenneth E Pengel, Jelle Wesseling, et al.
Breast (Edinburgh, Scotland)|January 15, 2013
Size does matter: High volume breast surgeons accept smaller excision margins for wide local excision--a national survey of the surgical management of wide local excision margins in UK breast cancer patientsAdam Hassani, Clive Griffith, James Harvey
Breast (Edinburgh, Scotland)|April 23, 2013
A nomogram for predicting underestimation of invasiveness in ductal carcinoma in situ diagnosed by preoperative needle biopsyHyung Seok Park, Ha Yan Kim, Seho Park, et al.
Breast (Edinburgh, Scotland)|April 23, 2013
International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)-MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancerNancy U Lin, Christoph Thomssen, Fatima Cardoso, et al.
Breast (Edinburgh, Scotland)|May 28, 2013
Feasibility and safety of dose-dense docetaxel after conventional epirubicin and cyclophosphamide as adjuvant treatment for early breast cancer patientsG Sanna, M Pestrin, E Zafarana, et al.
Pageof 365